Global Endoscopy Endo Reporting Unit — Net Sales
Boston Scientific Global Endoscopy Endo Reporting Unit — Net Sales increased by 1.6% to $759.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.8%, from $691.00M to $759.00M. Over 4 years (FY 2021 to FY 2025), Global Endoscopy Endo Reporting Unit — Net Sales shows an upward trend with a 8.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing demand for the company's gastrointestinal and pulmonary procedural solutions, while a decrease may signal market saturation or increased competition in the endoscopy space.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and equipment within the endoscopy b...
Peer comparison
Comparable to revenue reporting for specialized medical device segments in peer companies focused on gastrointestinal or interventional endoscopy markets.
bsx_segment_endoscopy_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $551.00M | $533.00M | $558.00M | $531.00M | $560.00M | $559.00M | $571.00M | $577.00M | $631.00M | $629.00M | $645.00M | $642.00M | $676.00M | $678.00M | $691.00M | $673.00M | $737.00M | $747.00M | $759.00M |
| QoQ Change | — | -3.3% | +4.7% | -4.8% | +5.5% | -0.2% | +2.1% | +1.1% | +9.4% | -0.3% | +2.5% | -0.5% | +5.3% | +0.3% | +1.9% | -2.6% | +9.5% | +1.4% | +1.6% |
| YoY Change | — | — | — | — | +1.6% | +4.9% | +2.3% | +8.7% | +12.7% | +12.5% | +13.0% | +11.3% | +7.1% | +7.8% | +7.1% | +4.8% | +9.0% | +10.2% | +9.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's global endoscopy endo reporting unit — net sales?
- Boston Scientific (BSX) reported global endoscopy endo reporting unit — net sales of $759.00M in Q4 2025.
- How has Boston Scientific's global endoscopy endo reporting unit — net sales changed year-over-year?
- Boston Scientific's global endoscopy endo reporting unit — net sales increased by 9.8% year-over-year, from $691.00M to $759.00M.
- What is the long-term trend for Boston Scientific's global endoscopy endo reporting unit — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's global endoscopy endo reporting unit — net sales has grown at a 8.0% compound annual growth rate (CAGR), from $2.14B to $2.92B.
- What does global endoscopy endo reporting unit — net sales mean?
- Total revenue generated from the sale of endoscopy-related medical devices and equipment.